REFERENCES
1. Lee M, Chang EB. Inflammatory bowel diseases (IBD) and the microbiome-searching the crime scene for clues. Gastroenterology. 2021;160:524-37.
2. Mentella MC, Scaldaferri F, Pizzoferrato M, Gasbarrini A, Miggiano GAD. Nutrition, IBD and gut microbiota: a review. Nutrients. 2020;12:944.
3. Rigottier-Gois L. Dysbiosis in inflammatory bowel diseases: the oxygen hypothesis. ISME J. 2013;7:1256-61.
4. Lee J-Y, Bays DJ, Savage HP, Bäumler AJ. The human gut microbiome in health and disease: time for a new chapter? Infect Immun. 2024;92:e0030224.
5. Verstockt B, Bressler B, Martinez-Lozano H, McGovern D, Silverberg MS. Time to revisit disease classification in inflammatory bowel disease: is the current classification of inflammatory bowel disease good enough for optimal clinical management? Gastroenterology. 2022;162:1370-82.
6. Cleynen I, Boucher G, Jostins L, et al. ; Interna tional Inflammatory Bowel Disease Genetics Consortium. Inherited determinants of Crohn’s disease and ulcerative colitis phenotypes: a genetic association study. Lancet. 2016;387:156-67.
7. Vestergaard MV, Allin KH, Eriksen C, et al. Gut microbiota signatures in inflammatory bowel disease. United European Gastroenterol J. 2024;12:22-33.
8. Zheng J, Sun Q, Zhang J, Ng SC. The role of gut microbiome in inflammatory bowel disease diagnosis and prognosis. United European Gastroenterol J. 2022;10:1091-102.
9. Hansen SH, Maseng MG, Grännö O, et al. Fecal microbiome reflects disease state and prognosis in inflammatory bowel disease in an adult population-based inception cohort. Inflamm Bowel Dis. 2025;31:2066-80.
10. Kugathasan S, Denson LA, Walters TD, et al. Prediction of complicated disease course for children newly diagnosed with Crohn’s disease: a multicentre inception cohort study. Lancet. 2017;389:1710-8.
11. Kristensen VA, Opheim R, Perminow G, et al. Inflammatory bowel disease in South-Eastern Norway III (IBSEN III): a new population-based inception cohort study from South-Eastern Norway. Scand J Gastroenterol. 2021;56:899-905.
12. Walmsley RS, Ayres RC, Pounder RE, Allan RN. A simple clinical colitis activity index. Gut. 1998;43:29-32.
14. Fadrosh DW, Ma B, Gajer P, et al. An improved dual-indexing approach for multiplexed 16S rRNA gene sequencing on the Illumina MiSeq platform. Microbiome. 2014;2:6.
15. Bushnell B. BBTools software package. Available from http://sourceforge. net/projects/bbmap. [accessed 17 March 2026].
16. Martin M. Cutadapt removes adapter sequences from high-throughput sequencing reads. EMBnet j. 2011;17:10.
17. Bushnell B, Rood J, Singer E. BBMerge - accurate paired shotgun read merging via overlap. PLoS ONE. 2017;12:e0185056.
18. Amir A, McDonald D, Navas-Molina JA, et al. Deblur rapidly resolves single-nucleotide community sequence patterns. mSystems. 2017;2:e00191-16.
19. Bolyen E, Rideout JR, Dillon MR, et al. Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2. Nat Biotechnol. 2019;37:852-7.
20. Bokulich NA, Kaehler BD, Rideout JR, et al. Optimizing taxonomic classification of marker-gene amplicon sequences with QIIME 2’s q2-feature-classifier plugin. Microbiome. 2018;6:90.
21. Quast C, Pruesse E, Yilmaz P, et al. The SILVA ribosomal RNA gene database project: improved data processing and web-based tools. Nucleic Acids Res. 2013;41:D590-6.
23. Granat R, Donnellan A, Heflin M, et al. Clustering analysis methods for GNSS observations: a data-driven approach to identifying California’s major faults. Earth Space Sci. 2021;8:e2021EA001680.
24. R Core Team. R: A language and environment for statistical computing; 2021. Vienna: R Foundation for Statistical Computing; 2021. Available from https://cran.rstudio.com/manuals.html. [accessed 17 March 2026].
26. Peyrin-Biroulet L, Panés J, Sandborn WJ, et al. Defining disease severity in inflammatory bowel diseases: current and future directions. Clin Gastroenterol Hepatol. 2016;14:348-354.e17.
27. Walsh AJ, Ghosh A, Brain AO, et al. Comparing disease activity indices in ulcerative colitis. J Crohns Colitis. 2014;8:318-25.
28. Ling Lundström M, Peterson C, Hedin CRH, et al. ; BIOIBD Consortium. Faecal biomarkers for diagnosis and prediction of disease course in treatment-naïve patients with IBD. Aliment Pharmacol Ther. 2024;60:765-77.
29. Aitchison J. The Statistical Analysis of Compositional Data. J R Stat Soc Ser B (Stat Methodol). 1982;44:139-60.
30. Gloor GB, Macklaim JM, Pawlowsky-Glahn V, Egozcue JJ. Microbiome datasets are compositional: and this is not optional. Front Microbiol. 2017;8:2224.
31. Henke MT, Kenny DJ, Cassilly CD, Vlamakis H, Xavier RJ, Clardy J. Ruminococcus gnavus, a member of the human gut microbiome associated with Crohn's disease, produces an inflammatory polysaccharide. Proc Natl Acad Sci U S A. 2019;116:12672-7.
32. Olbjørn C, Cvancarova Småstuen M, Thiis-Evensen E, et al. Fecal microbiota profiles in treatment-naïve pediatric inflammatory bowel disease - associations with disease phenotype, treatment, and outcome. Clin Exp Gastroenterol. 2019;12:37-49.
33. Nilsen M, Madelen Saunders C, Leena Angell I, et al. Butyrate levels in the transition from an infant- to an adult-like gut microbiota correlate with bacterial networks associated with eubacterium rectale and ruminococcus gnavus. Genes (Basel). 2020;11;1245.
34. Crost EH, Coletto E, Bell A, Juge N. Ruminococcus gnavus: friend or foe for human health. FEMS Microbiol Rev. 2023;47:fuad014.
35. Larsson JM, Karlsson H, Crespo JG, et al. Altered O-glycosylation profile of MUC2 mucin occurs in active ulcerative colitis and is associated with increased inflammation. Inflamm Bowel Dis. 2011;17:2299-307.
36. Bakir-Gungor B, Hacılar H, Jabeer A, Nalbantoglu OU, Aran O, Yousef M. Inflammatory bowel disease biomarkers of human gut microbiota selected via different feature selection methods. PeerJ. 2022;10:e13205.
37. Clooney AG, Eckenberger J, Laserna-Mendieta E, et al. Ranking microbiome variance in inflammatory bowel disease: a large longitudinal intercontinental study. Gut. 2021;70:499-510.
38. Vieira-Silva S, Falony G, Belda E, et al. ; MetaCardis Consortium. Statin therapy is associated with lower prevalence of gut microbiota dysbiosis. Nature. 2020;581:310-5.
39. Knights D, Ward TL, McKinlay CE, et al. Rethinking “enterotypes”. Cell Host Microbe. 2014;16:433-7.
40. Caenepeel C, Falony G, Machiels K, et al. Dysbiosis and associated stool features improve prediction of response to biological therapy in inflammatory bowel disease. Gastroenterology. 2024;166:483-95.
41. Vieira-Silva S, Sabino J, Valles-Colomer M, et al. Quantitative microbiome profiling disentangles inflammation- and bile duct obstruction-associated microbiota alterations across PSC/IBD diagnoses. Nat Microbiol. 2019;4:1826-31.
42. Reynders T, Devolder L, Valles-Colomer M, et al. Gut microbiome variation is associated to Multiple Sclerosis phenotypic subtypes. Ann Clin Transl Neurol. 2020;7:406-19.
43. Alili R, Belda E, Fabre O, et al. Characterization of the gut microbiota in individuals with overweight or obesity during a real-world weight loss dietary program: a focus on the bacteroides 2 enterotype. Biomedicines. 2021;10:16.
44. Togo AH, Diop A, Bittar F, et al. Correction to: Description of Mediterraneibacter massiliensis, gen. nov., sp. nov., a new genus isolated from the gut microbiota of an obese patient and reclassification of Ruminococcus faecis, Ruminococcus lactaris, Ruminococcus torques, Ruminococcus gnavus and Clostridium glycyrrhizinilyticum as Mediterraneibacter faecis comb. nov., Mediterraneibacter lactaris comb. nov., Mediterraneibacter torques comb. nov., Mediterraneibacter gnavus comb. nov. and Mediterraneibacter glycyrrhizinilyticus comb. nov. Antonie Van Leeuwenhoek. 2018;111:2129-30.
45. Shi Y, Zhang L, Peterson CB, Do KA, Jenq RR. Performance determinants of unsupervised clustering methods for microbiome data. Microbiome. 2022;10:25.
46. Koren O, Knights D, Gonzalez A, et al. A guide to enterotypes across the human body: meta-analysis of microbial community structures in human microbiome datasets. PLoS Comput Biol. 2013;9:e1002863.
47. Vandeputte D, Kathagen G, D’hoe K, et al. Quantitative microbiome profiling links gut community variation to microbial load. Nature. 2017;551:507-11.
48. Arumugam M, Raes J, Pelletier E, et al. ; MetaHIT Consortium. Enterotypes of the human gut microbiome. Nature. 2011;473:174-80.
49. Popov IV, Koopmans B, Venema K. Modulation of human gut microbiota by linear and branched fructooligosaccharides in an in vitro colon model (TIM-2). J Appl Microbiol. 2024;135:lxae170.[PMID:38986506 DOI:10. 1093/jambio/lxae170.
